EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
The Future of Pharma Partnerships: Strategic Alliances Driving Innovation
Beyond the Signing Ceremony Why Alliances Became the Industrys Growth EngineThere is a familiar photograph in pharmaceutical strategy two chief executives a signed term sheet a market capitalization moving
-
Techno Trends
FDA Authorises Aletta for Autonomous Blood Collection
The US Food and Drug Administration FDA has authorised Aletta the first standalone robotic device designed to collect blood from a patients arm without handson operator intervention
-
Projects
Cambrex Expands Milan R&D Operations With US$30 Million Investment
Cambrex has begun construction of a new research and development facility at its Profarmico Milano site in Italy supported by a US million investment The initiative is designed
-
Research Insights
CAVE-Onc: Graph-constrained agentic validation for cross-domain contradictions in CDISC oncology submissions
The CDISC Rules Engine CORE provides industrystandard validation for Study Data Tabulation Model SDTM submissions yet its imperative domainscoped architecture cannot express crossdomain contradictions
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Future of Pharma IT Infrastructure: Building Agile, Secure, and Data-Driven Enterprises
Lakshmi
American pharmaceutical companies are discovering that IT infrastructure sets the ceiling on everything else: how fast a product scales, how quickly quality issues surface, how far AI can be trusted....
-
2
Revolutionizing Healthcare: The Latest Innovations in Pharma Tech
Kate Williamson
In this article, the author discusses new tendencies of the pharmaceutical industry such as precision medicine, artificial intelligence in development of new drugs, wearable technology, 3D printing te...
-
3
Navigating the Evolution: Patient-Centric Approaches Transforming the Pharma Supply Chain
Kate Williamson
This article explores the transformative shift towards patient-centric supply chains in the pharmaceutical industry. It defines patient-centricity, examines technological innovations (IoT, blockchain,...
-
4
Curcumin’s Role as an Anti-Neurofibrillary Agent Towards Alzheimer's Disease
Sabrina Ruoyao Chen Zhang
Ronny Priefer
Alzheimer’s disease is a progressive neurodegenerative disease that afflicts millions of people globally. Symptoms typically present as memory loss and cognitive decline. Existing hypthoses focu...
-
5
RNA Revolution: Advancing Drug Discovery through Targeted Molecules
Kate Williamson
The RNA revolution in drug discovery has introduced targeted molecules like ASOs, siRNA, and RNA vaccines, offering precise gene modulation and therapeutic versatility across genetic disorders, neurod...
press releasesRead more...
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial
EpilepsyGTx a biotechnology company developing gene therapies for refractory epilepsy and Viralgen a leading contract development and manufacturing organization CDMO specialising in recombinant
Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery
Revvity Inc NYSE RVTY today announced it has entered into a definitive agreement to acquire Human Cell Design HCD a Francebased biotechnology company specializing in human cell models and preclinical research solutions
Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines
Gilead Sciences Inc Nasdaq GILD today celebrated the opening of its squarefoot Research Center at its Foster City headquarters expanding capabilities in oncology inflammation and research data
Flow Technology partners with BW Forsyth Partners to Meet Growing Demand for Biopharmaceutical Manufacturing
Flow Technology a provider of engineered process systems and skid integration solutions serving the global life sciences industry announced a partnership with BW Forsyth Partners that will support the companys
Events Read more...
09 - 10
Sep 2026iPSC Drug Development Summit
Hyatt Regency Boston Harbour,...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
LATEST NEWSRead more...
Lotus Neuro launches to advance targeted therapies across the blood-brain barrier
Lotus Neuro a clinicalstage biotechnology company focused on neurological diseases has announced its public launch The company combines focused ultrasound with existing therapeutic approaches to improve the delivery of medicines across the bloodbrain barrier BBB
Sobi receives US FDA Fast Track designation for pacritinib in VEXAS syndrome
Sobi North America the North American affiliate of Swedish Orphan Biovitrum Sobi has announced that the US Food and Drug Administration FDA has granted Fast Track designation to pacritinib for the treatment of VEXAS syndrome
Sernova and Seraxis to Merge and Form BetaNova Biotherapeutics for Type 1 Diabetes Cell Replacement
Sernova Biotherapeutics Inc and Seraxis Holdings Inc have entered into a definitive merger agreement to combine their technologies and create BetaNova Biotherapeutics a clinicalstage biotechnology
RiboX Therapeutics Receives FDA RMAT Designation for RXRG001
RiboX Therapeutics has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration FDA for RXRG an investigational treatment
Lupin receives US FDA approval for Modafinil tablets
Lupin has received approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for Modafinil Tablets USP mg and mg
AtomVie opens new radiopharmaceutical manufacturing facility in Ontario
AtomVie Global Radiopharma AtomVie a contract development and manufacturing organisation CDMO specialising in radiopharmaceuticals has opened a new manufacturing facility in Hamilton Ontario
